TRIFLUPROMAZINE HYDROCHLORIDE

First approved in 1957

Details

Stereochemistry	ACHIRAL
Molecular Formula	C18H19F3N2S.ClH
Molecular Weight	388.878
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of TRIFLUPROMAZINE HYDROCHLORIDE

Structure Search

SMILES

Cl.CN(C)CCCN1C2=C(SC3=C1C=C(C=C3)C(F)(F)F)C=CC=C2

InChI

InChIKey=FTNWXGFYRHWUKG-UHFFFAOYSA-N

InChI=1S/C18H19F3N2S.ClH/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21;/h3-4,6-9,12H,5,10-11H2,1-2H3;1H

HIDE SMILES / InChI

Molecular Formula	C18H19F3N2S
Molecular Weight	352.417
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: http://www.druglib.com/activeingredient/triflupromazine

Triflupromazine is antipsychotic and an antiemetic drug (sold under the brand names VESPRIN) which used to management of psychoses. However, this drug was discontinued. Triflupromazine binds to the dopamine D1 and dopamine D2 receptors and inhibits their activity. Moreover, binds the muscarinic acetylcholine receptors (M1 and M2).

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Muscarinic acetylcholine receptor M1 169 Target ID: P11229 Gene ID: 1128.0 Gene Symbol: CHRM1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/1678146	Antagonist 2778
Muscarinic acetylcholine receptor M2 121 Target ID: P08172 Gene ID: 1129.0 Gene Symbol: CHRM2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/4152054	Antagonist 2778
Dopamine D1 receptor 101 Target ID: CHEMBL2056 Sources: http://www.druglib.com/activeingredient/triflupromazine/	Antagonist 2778
Dopamine D2 receptor 297 Target ID: CHEMBL217 Sources: http://www.druglib.com/activeingredient/triflupromazine/	Antagonist 2778

Conditions

Condition	Modality	Targets	Highest Phase	Product
Psychosis 16 Sources: http://www.druglib.com/activeingredient/triflupromazine/	Primary		Approved 8429	VESPRIN Approved Use Used mainly in the management of psychoses. Also used to control nausea and vomiting Launch Date 1957

Doses

Dose	Population	Adverse events
800 mg 1 times / day multiple, oral Overdose Dose: 800 mg, 1 times / day Route: oral Route: multiple Dose: 800 mg, 1 times / day Sources: http://www.jodrugs.com/products/39197-triflupromazine.aspx#cite4_de	unhealthy Health Status: unhealthy Condition: Psychotic disorders Sources: http://www.jodrugs.com/products/39197-triflupromazine.aspx#cite4_de	Sources: http://www.jodrugs.com/products/39197-triflupromazine.aspx#cite4_de
150 mg 1 times / day multiple, intramuscular Recommended Dose: 150 mg, 1 times / day Route: intramuscular Route: multiple Dose: 150 mg, 1 times / day Sources: http://www.jodrugs.com/products/39197-triflupromazine.aspx#cite4_de	unhealthy Health Status: unhealthy Condition: Psychotic disorders Sources: http://www.jodrugs.com/products/39197-triflupromazine.aspx#cite4_de	Sources: http://www.jodrugs.com/products/39197-triflupromazine.aspx#cite4_de
3 mg 1 times / day multiple, intravenous Recommended Dose: 3 mg, 1 times / day Route: intravenous Route: multiple Dose: 3 mg, 1 times / day Sources: http://www.jodrugs.com/products/39197-triflupromazine.aspx#cite4_de	unhealthy Health Status: unhealthy Condition: Nausea Sources: http://www.jodrugs.com/products/39197-triflupromazine.aspx#cite4_de	Sources: http://www.jodrugs.com/products/39197-triflupromazine.aspx#cite4_de

Sourcing

Vendor/Aggregator	ID	URL
ChEBI	CHEBI:9711	https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9711
ZINC	ZINC000000538507	http://zinc15.docking.org/substances/ZINC000000538507
eMolecules	1989361	https://www.emolecules.com/cgi-bin/more?vid=1989361

PubMed

Title	Date	PubMed
A case report of akathisia due to triflupromazine.	1971 Apr	5558821
[Four cases of extrapyramidal effects following the treatment of hyperemesis gravidarum with triflupromazin (author's transl)].	1976 Apr	936714
Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.	1984 Sep	6147851
Activation of Maxi Cl(-) channels by antiestrogens and phenothiazines in NIH3T3 fibroblasts.	2002 May	11960619
Trans-cellular proliferating cell nuclear antigen gene activation in cerebral vascular smooth muscle by endothelial oxidative injury in vivo.	2003 Nov 1	12969989
Thermodynamics of partitioning of phenothiazine drugs between phosphatidylcholine bilayer vesicles and water studied by second-derivative spectrophotometry.	2003 Sep	12951447
Triflupromazine: a microbicide non-antibiotic compound.	2004	15362289
Romifidine-ketamine anaesthesia in atropine and triflupromazine pre-medicated buffalo calves.	2004 Dec	15610485
Dissociation constants of phenothiazine drugs incorporated in phosphatidylcholine bilayer of small unilamellar vesicles as determined by carbon-13 nuclear magnetic resonance spectrometric titration.	2004 Feb 10	14967475
19F NMR spectroscopic study on the binding of triflupromazine to bovine and human serum albumins.	2004 Oct 29	15496337
Effects of phosphatidylserine and phosphatidylethanolamine content on partitioning of triflupromazine and chlorpromazine between phosphatidylcholine-aminophospholipid bilayer vesicles and water studied by second-derivative spectrophotometry.	2005 Jan	15635254
Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials.	2005 Oct 17	16229742
A kinetic study on the phenothiazine dependent oxidation of NADH by bovine ceruloplasmin.	2006 Feb	16502325
Effects of inorganic ions on the binding of triflupromazine and chlorpromazine to bovine serum albumin studied by spectrometric methods.	2006 Jul	16819214
Trypanosoma cruzi dihydrolipoamide dehydrogenase as target for phenothiazine cationic radicals. Effect of antioxidants.	2006 Sep	17017892
Synthesis and antitubercular activity of quaternized promazine and promethazine derivatives.	2007 Mar 1	17188865
[Derivative spectrophotometric and NMR spectroscopic study in pharmaceutical science].	2007 Oct	17917421
Analytical Applications of Reactions of Iron(III) and Hexacyanoferrate(III) with 2,10-Disubstituted Phenothiazines.	2009	20107561
Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II.	2009 Dec	20514211
Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses.	2009 Jun 1	19461075
Effects of chemical manipulation of mitotic arrest and slippage on cancer cell survival and proliferation.	2009 Sep 15	19713760
Molecularly imprinted polymers as analyte sequesters and selective surfaces for easy ambient sonic-spray ionization.	2010 Apr	20309446
Experimental analyses of synergistic combinations of antibiotics with a recently recognised antibacterial agent, lacidipine.	2010 Feb	20012879
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle.	2010 Feb 23	20142494
Research on antipsychotics in India.	2010 Jan	21836703
The identification of inhibitors of Schistosoma mansoni miracidial transformation by incorporating a medium-throughput small-molecule screen.	2010 Jun	20060828
Phenothiazine-type antipsychotics elicit cutaneous analgesia in rats.	2010 Mar	20434106
Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology.	2010 Mar 3	20209133
Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.	2013 Jun	23529728

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Intramuscular

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Sat Dec 16 05:13:19 GMT 2023` Edited by `admin` on `Sat Dec 16 05:13:19 GMT 2023`
Record UNII	9E75N4A5HM
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TRIFLUPROMAZINE HYDROCHLORIDE

Common Name

English

TRIFLUPROMAZINE HCL

Common Name

English

TRIFLUPROMAZINE HYDROCHLORIDE [VANDF]

Common Name

English

TRIFLUPROMAZINE HYDROCHLORIDE [GREEN BOOK]

Common Name

English

NSC-14959

Code

English

TRIFLUPROMAZINE HYDROCHLORIDE [MART.]

Common Name

English

10-[3-(Dimethylamino)propyl]-2-(trifluoromethyl)phenothiazine monohydrochloride

Systematic Name

English

TRIFLUPROMAZINE HYDROCHLORIDE [USP MONOGRAPH]

Common Name

English

TRIFLUPROMAZINE HYDROCHLORIDE [JAN]

Common Name

English

NSC-17473

Code

English

TRIFLUPROMAZINE HYDROCHLORIDE [MI]

Common Name

English

TRIFLUPROMAZINE HYDROCHLORIDE [USP-RS]

Common Name

English

MC-4703

Code

English

Triflupromazine hydrochloride [WHO-DD]

Common Name

English

TRIFLUPROMAZINE HYDROCHLORIDE [ORANGE BOOK]

Common Name

English

10H-PHENOTHIAZINE-10-PROPANAMINE, N,N-DIMETHYL-2-(TRIFLUOROMETHYL)-, MONOHYDROCHLORIDE

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C740